Cargando…

Risk Factors for Acute Kidney Injury Induced by Intravenous Polymyxin B in Chinese Patients with Severe Infection

PURPOSE: To analyze the risk factors for acute kidney injury (AKI) induced by intravenous polymyxin B in Chinese patients with severe infection and to provide a reference for clinicians and pharmacists. METHODS: We retrospectively analyzed patients treated with intravenous polymyxin B from August 20...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jia, Xuedong, Guo, Cuohui, Yin, Zhao, Zhang, Wan, Du, Shuzhang, Zhang, Xiaojian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9034847/ https://www.ncbi.nlm.nih.gov/pubmed/35469305 http://dx.doi.org/10.2147/IDR.S363944

Ejemplares similares

Effectiveness and Nephrotoxicity of Intravenous Polymyxin B in Carbapenem-Resistant Gram-Negative Bacterial Infections Among Chinese Children
por: Jia, Xuedong, et al.
Publicado: (2022)

The Efficacy and Influencing Factors of Polymyxin B in High-Level Carbapenem-Resistant Klebsiella pneumoniae Infections
por: Jia, Xuedong, et al.
Publicado: (2023)

Polymyxin Acute Kidney Injury: a case of severe tubulopathy
por: Goldin, Lucas Alexandre de Mello, et al.
Publicado: (2021)

Effectiveness and Nephrotoxicity of Intravenous Polymyxin B in Chinese Patients With MDR and XDR Nosocomial Pneumonia
por: Zeng, Huihui, et al.
Publicado: (2021)

Exploring the Pharmaceutical Care of Pharmacists in China During COVID-19—A National Multicenter Qualitative Study
por: Wang, Mingxia, et al.
Publicado: (2022)

Polymyxin B-Induced Kidney Injury Assessment of a Novel Formulation of Polymyxin B (VRP-034) in Rats
por: Roy, Dilip, et al.
Publicado: (2021)

Correlation between the drug concentration of polymyxin B and polymyxin B‐associated acute kidney injury in critically ill patients: A prospective study
por: Xu, Ying, et al.
Publicado: (2022)

What Is the Role of Pharmacists in Treating COVID-19 Patients? The Experiences and Expectations of Front Line Medical Staff
por: Jia, Xuedong, et al.
Publicado: (2021)

Factors associated with burnout and job satisfaction in Chinese hospital pharmacists
por: Zhao, Jie, et al.
Publicado: (2020)

Drug-drug cocrystals: Opportunities and challenges
por: Wang, Xiaojuan, et al.
Publicado: (2021)

Psychological distress of frontline healthcare workers in the intensive care unit during the early stage of the COVID-19 pandemic: a qualitative study from China
por: Yin, Zhao, et al.
Publicado: (2022)

Polymyxin Acute Kidney Injury: Dosing and Other Strategies to Reduce Toxicity
por: Nation, Roger L., et al.
Publicado: (2019)

Efficacy and safety of novel oral anticoagulants in patients with atrial nonvalvular atrial fibrillation and diabetes mellitus: a systematic review and meta-analysis
por: Jia, Xuedong, et al.
Publicado: (2022)

Exploring the perceptions and barriers of nurses working in remote areas on tele-educational delivery of pharmacy knowledge in Henan, China: a qualitative study
por: Zhang, Wan, et al.
Publicado: (2022)

To study the clinical efficacy and nephrotoxicity along with the risk factors for acute kidney injury associated with parenteral polymyxin B
por: Nandha, Ruchika, et al.
Publicado: (2013)

Population Pharmacokinetics of Polymyxin B in Obese Patients for Resistant Gram-Negative Infections
por: Wang, Peile, et al.
Publicado: (2021)

Exploring the experiences and expectations of pharmacist interns in large general hospitals in China: from the perspective of interns
por: Yao, Xiali, et al.
Publicado: (2022)

Assessing the predictive performance of population pharmacokinetic models for intravenous polymyxin B in critically ill patients
por: Hanafin, Patrick O., et al.
Publicado: (2021)

Population Pharmacokinetics and Limited Sampling Strategy for Therapeutic Drug Monitoring of Polymyxin B in Chinese Patients With Multidrug-Resistant Gram-Negative Bacterial Infections
por: Wang, Peile, et al.
Publicado: (2020)

1569. A Translational Model to Assess the Impact of Polymyxin B Dose Fractionation on Kidney Injury
por: Liu, Jiajun, et al.
Publicado: (2019)

The Impact of Acute Kidney Injury on the Risk of Mortality and Health Care Utilization Among Patients Treated With Polymyxins for Severe Gram-Negative Infections
por: Baradaran, Sarah, et al.
Publicado: (2018)

A qualitative study on the working experiences of clinical pharmacists in fighting against COVID-19
por: Wang, Xiaojuan, et al.
Publicado: (2022)

Organ donation decision-making in ICU patients: from the perspectives of organ coordinators and physicians in China – a qualitative study
por: Yang, Xi, et al.
Publicado: (2023)

The Difference Between Polymyxin B and Polymyxin E in Causing Skin Hyerpigmentation
por: Zou, Dongna, et al.
Publicado: (2021)

Transcriptomic Responses to Polymyxin B and Analogues in Human Kidney Tubular Cells
por: Li, Mengyao, et al.
Publicado: (2023)

Efficacy and safety of intravenous combined with aerosolised polymyxin versus intravenous polymyxin alone in the treatment of multidrug-resistant gram-negative bacterial pneumonia: A systematic review and meta-analysis
por: Lu, Difan, et al.
Publicado: (2023)

Polymyxin B Etest Fails to Distinguish Carbapenem-resistant Enterobacteriaceae with Elevated Polymyxin B MICs
por: Kulengowski, Brandon, et al.
Publicado: (2017)

Assessing the Risk of Nephrotoxicity Associated With Non-renally Adjusted Intravenous Polymyxin B Compared with Traditional Dosing
por: Maniara, Bejoy, et al.
Publicado: (2017)

Modulation of inflammatory response related to severe peritonitis by polymyxin-B haemoperfusion
por: Coudroy, R, et al.
Publicado: (2015)

Transcriptional responses of Burkholderia cenocepacia to polymyxin B in isogenic strains with diverse polymyxin B resistance phenotypes
por: Loutet, Slade A, et al.
Publicado: (2011)

Polymyxin B-Induced Skin Hyperpigmentation
por: Wen, Xueke, et al.
Publicado: (2020)

Qualitative research on the work experience of pharmacists in fever clinics and isolation wards of designated hospitals for novel coronavirus pneumonia (COVID-19)
por: Hao, Jie, et al.
Publicado: (2021)

Resveratrol enhances the antimicrobial effect of polymyxin B on Klebsiella pneumoniae and Escherichia coli isolates with polymyxin B resistance
por: Liu, Li, et al.
Publicado: (2020)

Nutritional Support and Clinical Outcome of Severe and Critical Patients With COVID-19 Pneumonia
por: Yue, Xiangfeng, et al.
Publicado: (2020)

Intravenous Calcium Alginate Microspheres as Drug Delivery Vehicles in Acute Kidney Injury Treatment
por: Man, Jia, et al.
Publicado: (2022)

Effect of Hemoperfusion Using Polymyxin B-immobilized Fibers on Acute Lung Injury in a Rat Sepsis Model
por: Iba, Toshiaki, et al.
Publicado: (2014)

Intravenous Microinjections of Zebrafish Larvae to Study Acute Kidney Injury
por: Cianciolo Cosentino, Chiara, et al.
Publicado: (2010)

Polymyxin B and fusidic acid, a novel potent synergistic combination against Klebsiella pneumoniae and Escherichia coli isolates with polymyxin B resistance
por: Chen, Shuying, et al.
Publicado: (2023)

Efficacy of polymyxin B hemoperfusion in and beyond septic shock: is an “endotoxin severity score” needed?
por: Honore, Patrick M., et al.
Publicado: (2018)

Colistin and polymyxin B: A re-emergence
por: Gupta, Sachin, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_vi6jj30q4cihoot4imc27tcb5j